Science Explorer Back to mapMap
Discussion
Company · Rochester · United States

Vaccinex (United States)

vaccinex.comROR OpenAlex
Research works
68
▲ 65% vs 2018-21
Citations
1.4k
20.7 per fractional work
Top-10% rate
9.9%
all institutions 10.0%
Open access
38%
world 40%
International
11%
world 18%
Vaccinex (United States)

Not ranked overall: Vaccinex (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Vaccinex (United States) work in?

In all years, 68% of research at Vaccinex (United States) is in Life Sciences, 31% in Health Sciences. Its largest fields are Medicine (30%), Neuroscience (24%), Biochemistry, Genetics and Molecular Biology (23%). It does 3.7× the world's share of Life Sciences.

Life Sciences: 46 fractional works · 67.9% of its workNeuroscience: 16 fractional works · 23.7% of its workCellular and Molecular Neuroscience: 15 fractional works · 22.3% of its workNeurology: 1 fractional works · 0.8% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workBiochemistry, Genetics and Molecular Biology: 15 fractional works · 22.8% of its workMolecular Biology: 12 fractional works · 17.9% of its workGenetics: 1 fractional works · 2.0% of its workCell Biology: 1 fractional works · 1.4% of its workCancer Research: 1 fractional works · 0.9% of its workBiotechnology: 0 fractional works · 0.5% of its workImmunology and Microbiology: 13 fractional works · 19.8% of its workImmunology: 12 fractional works · 18.0% of its workVirology: 1 fractional works · 1.2% of its workMicrobiology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 0.9% of its workPlant Science: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmaceutical Science: 0 fractional works · 0.6% of its workHealth Sciences: 21 fractional works · 31.2% of its workMedicine: 20 fractional works · 29.7% of its workOncology: 6 fractional works · 9.4% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 4.5% of its workEpidemiology: 2 fractional works · 2.9% of its workPharmacology: 2 fractional works · 2.2% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.7% of its workImmunology and Allergy: 1 fractional works · 1.3% of its workSurgery: 1 fractional works · 1.0% of its workNeurology: 1 fractional works · 0.8% of its workInfectious Diseases: 1 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.6% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.5% of its workGastroenterology: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workDermatology: 0 fractional works · 0.3% of its workOtorhinolaryngology: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workRheumatology: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.6% of its workSpeech and Hearing: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.6% of its workSmall Animals: 0 fractional works · 0.6% of its workDentistry: 0 fractional works · 0.4% of its workPeriodontics: 0 fractional works · 0.4% of its workPhysical Sciences: 0 fractional works · 0.6% of its workEngineering: 0 fractional works · 0.5% of its workBiomedical Engineering: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.0% of its workSocial Sciences: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.3% of its workALL ITS WORKVaccinex (UnitedStates)68fractional works, all years
Life Sciences68%Physical Sciences1%Health Sciences31%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Neuroscience1623.7%
    2. Biochemistry, Genetics and Molecular Biology1522.8%
    3. Immunology and Microbiology1319.8%
    4. Agricultural and Biological Sciences10.9%
    5. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Medicine2029.7%
    2. Health Professions00.6%
    3. Veterinary00.6%
    4. Dentistry00.4%
    1. Engineering00.5%
    2. Environmental Science00.1%
    3. Computer Science00.0%
    1. Social Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.23× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.86× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 28.23× its world share, 5 worksImmunology and Micro…Neuroscience: 15.05× its world share, 4 worksNeuroscienceComputer Science: 0.02× its world share, 0 worksComputer ScienceMedicine: 1.57× its world share, 5 worksMedicineSocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 28.2×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Immunology and Microbiology28.23×5 works
  2. Neuroscience15.05×4 works
  3. Biochemistry, Genetics and Molecular Biology2.86×2 works
  4. Medicine1.57×5 works
  5. Agricultural and Biological Sciences0.23×0 works
  6. Social Sciences0.04×0 works
  7. Computer Science0.02×0 works

Who are the top researchers at Vaccinex (United States)?

Ranked on the quality score, Alan S. Jonason, Ernest Smith and Janaki Veeraraghavan lead among researchers whose main affiliation is Vaccinex (United States).

  1. 1 Alan S. Jonason United States · #394,923 worldwide 4.3k citations · 35 works
  2. 2 Ernest Smith United States · #795,117 worldwide 1.1k citations · 85 works
  3. 3 Janaki Veeraraghavan United States · #916,649 worldwide 898 citations · 23 works
  4. 4 Sebold Torno United States · #1,229,964 worldwide 431 citations · 33 works
  5. 5 Crystal L. Mallow United States · #1,318,794 worldwide 481 citations · 74 works
  6. 6 Christine A. Reilly United States · #1,470,482 worldwide 676 citations · 59 works
  7. 7 Mark J. Paris United States · #1,501,054 worldwide 1.4k citations · 36 works
  8. 8 Maria Scrivens United States · #1,507,133 worldwide 326 citations · 40 works
  9. 9 John E. Leonard United States · #1,548,197 worldwide 1.5k citations · 113 works
  10. 10 Holm Bußler United States · #1,579,711 worldwide 484 citations · 47 works
All ranked researchers at Vaccinex (United States)

What are the most cited papers from Vaccinex (United States)?

The most cited paper from Vaccinex (United States) is "Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene" (Yasuhiko Nishio, Yufeng Dong, Mark J. Paris et al., 2006), with 346 citations. Next come "A biological classification of Huntington's disease: the Integrated Staging System" (336) and "CXCL13 antibody for the treatment of autoimmune disorders" (127).

Most cited papers
#PaperReleasedCitations
1 Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene Yasuhiko Nishio, Yufeng Dong, Mark J. Paris et al. · Gene 30 Mar 2006 346
2 A biological classification of Huntington's disease: the Integrated Staging System Sarah J. Tabrizi, Scott Schobel, Emily C. Gantman et al. · The Lancet Neurology 15 Jun 2022 336
3 CXCL13 antibody for the treatment of autoimmune disorders Ekaterina Klimatcheva, Tracy Pandina, Christine A. Reilly et al. · BMC Immunology Open access 10 Feb 2015 127
4 SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease Ernest Smith et al. · Neurobiology of Disease Open access 18 Oct 2014 121
5 CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis Jill M. Kramer, Ekaterina Klimatcheva, Thomas L. Rothstein · Journal of Leukocyte Biology Open access Aug 2013 120
All 89 most cited papers, with filters and sorting

Which keywords describe research at Vaccinex (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Receptor tyrosine kinases, Cell Signaling, Eph receptors, Semaphorins, Cancer Immunotherapy, endothelial progenitor cells, VEGF and Immunity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Receptor tyrosine kinases14▲ 466×2 topics
  2. Cell Signaling14▲ 60×3 topics
  3. Eph receptors13▲ 1409×1 topic
  4. Semaphorins13▲ 1409×1 topic
  5. Cancer Immunotherapy7▲ 71×3 topics
  6. VEGF5▲ 226×1 topic
  7. endothelial progenitor cells5▲ 226×1 topic
  8. Immunity5▲ 21×6 topics
  9. Immunotherapy4▲ 10×9 topics
  10. Epidemiology4▲ 1.63×19 topics
  11. Inflammation4▲ 2.8×12 topics
  12. Glycosylation4▲ 29×3 topics
  13. Cancer3▲ 3.6×9 topics
  14. Monoclonal Antibodies3▲ 34×3 topics
  15. Innate Immunity3▲ 13×4 topics
  16. Therapeutic Antibodies3▲ 36×2 topics
  17. Autoimmunity3▲ 21×4 topics
  18. Angiogenesis3▲ 10×5 topics
  19. Antibody Engineering3▲ 41×1 topic
  20. Antigen Presentation3▲ 41×2 topics
  21. Fc Receptors3▲ 41×1 topic
  22. Dendritic Cells2▲ 33×1 topic
  23. Lymphoma2▲ 25×3 topics
  24. Tumor Antigen2▲ 46×1 topic
  25. Tumor Regression2▲ 40×2 topics
  26. CAR T Cells2▲ 75×1 topic
  27. Chimeric Antigen Receptor2▲ 75×1 topic
  28. NK Cell Recognition2▲ 32×1 topic
  29. Natural Killer Cells2▲ 32×1 topic
  30. CD472▲ 190×1 topic
  31. Foxp32▲ 40×1 topic
  32. Immune Response2▲ 4.8×9 topics
  33. TGF-ß2▲ 17×1 topic
  34. apoptotic cells2▲ 190×1 topic
  35. Tumor Microenvironment2▲ 7.9×3 topics
  36. Mitochondrial Dysfunction2▲ 7.3×4 topics
  37. Monoclonal Antibody2▲ 37×2 topics
  38. Neuroprotective2▲ 18×2 topics
  39. Protein Aggregation2▲ 27×2 topics
  40. Targeted Therapy2▲ 10×5 topics

Which research topics does Vaccinex (United States) publish most on?

By volume in 2022-now: Axon Guidance and Neuronal Signaling, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses and Cancer Immunotherapy and Biomarkers.

Axon Guidance and Neuronal Signaling: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksGenetic Neurodegenerative Diseases: 1 fractional worksT-cell and B-cell Immunology: 1 fractional worksPhagocytosis and Immune …1Phagocytosis and Immune Regulation: 1 fractional worksCAR-T cell therapy research: 1 fractional worksImmune Cell Function and Interaction: 1 fractional worksMitochondrial Function and Pathology: 0 fractional works
Cellular and Molecular NeuroscienceRadiology, Nuclear Medicine and ImagingImmunologyOncology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Axon Guidance and Neuronal Signaling Cellular and Molecular Neuroscience 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  3. 3 Immunotherapy and Immune Responses Immunology 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works
  6. 6 T-cell and B-cell Immunology Immunology 1 works
  7. 7 Phagocytosis and Immune Regulation Immunology 1 works
  8. 8 CAR-T cell therapy research Oncology 1 works
  9. 9 Immune Cell Function and Interaction Immunology 1 works
  10. 10 Mitochondrial Function and Pathology Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.1%not open61.9%

World: 40% of research is openly available.

with international co-authors11.0%domestic only89.0%

World: 18% is written across borders.

How has Vaccinex (United States)'s research output changed?

Output in 2022-2025 was 65% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vaccinex (United States) as a percentage of every work published that year, 0.000045% in 2024.

still counting0.00020%0.00040%0.00060%Vaccinex (United States)0.000057% in 202519801990200020102020

Fractional works of Vaccinex (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rochester

All research institutions in Rochester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Vaccinex (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.